ProCE Banner Activity

From CROI 2022: Week 152 ATLAS-2M Results on LA ART and Implications for Patients

Conference Coverage
Clinical Thought
Here’s why I think it is important to combine the science and art of medicine to keep patients at the forefront of decision-making for long-acting ART.

Released: March 15, 2022

Expiration: March 14, 2023

Share

Faculty

Babafemi Taiwo

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Cepheid

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS, has disclosed that he has received consulting fees from Gilead Sciences, Merck, and ViiV Healthcare/GSK and independent contractor fees from Johnson & Johnson.